1. Home
  2. SONN vs POLA Comparison

SONN vs POLA Comparison

Compare SONN & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • POLA
  • Stock Information
  • Founded
  • SONN N/A
  • POLA 1979
  • Country
  • SONN United States
  • POLA United States
  • Employees
  • SONN N/A
  • POLA N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • POLA Industrial Machinery/Components
  • Sector
  • SONN Health Care
  • POLA Miscellaneous
  • Exchange
  • SONN Nasdaq
  • POLA Nasdaq
  • Market Cap
  • SONN 3.8M
  • POLA 4.3M
  • IPO Year
  • SONN N/A
  • POLA 2016
  • Fundamental
  • Price
  • SONN $3.99
  • POLA $2.11
  • Analyst Decision
  • SONN Strong Buy
  • POLA
  • Analyst Count
  • SONN 1
  • POLA 0
  • Target Price
  • SONN $20.00
  • POLA N/A
  • AVG Volume (30 Days)
  • SONN 11.6M
  • POLA 293.3K
  • Earning Date
  • SONN 08-13-2025
  • POLA 08-13-2025
  • Dividend Yield
  • SONN N/A
  • POLA N/A
  • EPS Growth
  • SONN N/A
  • POLA N/A
  • EPS
  • SONN N/A
  • POLA N/A
  • Revenue
  • SONN $1,000,000.00
  • POLA $13,918,000.00
  • Revenue This Year
  • SONN $5,376.22
  • POLA N/A
  • Revenue Next Year
  • SONN N/A
  • POLA N/A
  • P/E Ratio
  • SONN N/A
  • POLA N/A
  • Revenue Growth
  • SONN 978.39
  • POLA 8.08
  • 52 Week Low
  • SONN $1.08
  • POLA $1.53
  • 52 Week High
  • SONN $19.30
  • POLA $4.69
  • Technical
  • Relative Strength Index (RSI)
  • SONN 47.24
  • POLA 62.34
  • Support Level
  • SONN $4.16
  • POLA $2.02
  • Resistance Level
  • SONN $19.30
  • POLA $2.25
  • Average True Range (ATR)
  • SONN 1.98
  • POLA 0.13
  • MACD
  • SONN -0.41
  • POLA 0.02
  • Stochastic Oscillator
  • SONN 1.03
  • POLA 68.18

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

Share on Social Networks: